KETAMINE HCL

Add Drug

Prices & Coupons

133RD STREET PHARMACY INC

1473 Amsterdam Ave
New York NY 10027
(212)491-4911

$6.40

Get Your Coupon

AHF PHARMACY

475 Atlantic Ave
Brooklyn NY 11217
(718)637-2970

$6.40

Get Your Coupon 1 more results found for AIDS HEALTHCARE FOUNDATION

AHF PHARMACY

2307 Astoria Blvd
Astoria NY 11102
(718)545-2550

$6.40

Get Your Coupon

ALICE RX CORP

231 S 3 Rd St
Brooklyn NY 11211
(718)502-6969

$6.40

Get Your Coupon 14 more results found for PHARMACY FIRST

DANNY'S PHARMACY II

110 W End Ave
New York NY 10023
(212)362-0000

$6.40

Get Your Coupon

A.M. PHARMACY II, INC

223 Grand Street
New York NY 10013
(212)226-8832

$6.50

Get Your Coupon 16 more results found for ALIGNRX (783)

HUDSON PHARMACY

65 08 Roosevelt Avenue
Woodside NY 11377
(347)448-6965

$6.50

Get Your Coupon

ACME PHARMACY #1083

125 18 Th St
Jersey City NJ 07310
(201)418-0585

$6.68

Get Your Coupon 1 more results found for NEW ALBERTSONS LP

1699 FANCY PHARMACY INC

132 Allen St
New York NY 10002
(212)529-4532

$7.00

Get Your Coupon 54 more results found for ELEVATE PROVIDER NETWORK 904

COLUMBUS AVE PHARMACY

916 Columbus Ave
New York NY 10025
(212)663-7440

$7.00

Get Your Coupon 21 more results found for EPIC PHARMACY NETWORK INC

MOUNT SINAI PHARMACY AT CAM

17 East 102 Nd St
New York NY 10029
(212)824-7064

$7.00

Get Your Coupon

139 CENTER PHARMACY, LLC

139 Centre Street
New York NY 10013
(646)838-6388

$7.40

Get Your Coupon 135 more results found for LEADER DRUG STORES INC

137 MOTT PHARMACY, INC.

137 Mott St
New York NY 10013
(646)669-8220

$7.50

Get Your Coupon 23 more results found for HEALTH MART ATLAS 605

79TH STREET PHARMACY

215 W 79 Th St
New York NY 10024
(646)370-5978

$7.50

Get Your Coupon 26 more results found for HEALTH MART ATLAS 630

ECHO CARE SPECIALTY PHARMACY

260 Broadway
Brooklyn NY 11211
(718)782-3030

$7.50

Get Your Coupon

CARE PLUS CVS/PHARMACY #02546

1200 Harbor Blvd
Weehawken NJ 07086
(201)330-8147

$8.00

Get Your Coupon 77 more results found for CVS PHARMACY INC

CVS PHARMACY # 17820

10 Union Sq E
New York NY 10003
(212)895-9917

$8.00

Get Your Coupon 11 more results found for CVS PHARMACY IN TARGET

CVS PHARMACY #02919

126 Eighth Ave
New York NY 10011
(800)362-7828

$8.00

Get Your Coupon

COMMUNITY, A WALGREENS PHARMACY #16463

29 W 116 Th St
New York NY 10026
(212)519-8346

$12.00

Get Your Coupon 81 more results found for WALGREENS DRUG STORE

APICHA HEALTH CENTER PHARMACY

400 Broadway
New York NY 10013
(844)370-6202

$12.50

Get Your Coupon 4 more results found for MAXORXPRESS

CHELSEA ROYAL CARE PHARMACY, INC.

154 9 Th Ave
New York NY 10011
(212)255-8000

$12.50

Get Your Coupon

CHRONOS PHARMACY

30 96 36 Th Street
Astoria NY 11103
(718)932-8700

$12.50

Get Your Coupon

COLUMBIA DRUGS

55 Columbia St
New York NY 10002
(212)533-8120

$12.50

Get Your Coupon

CONTIGO PHARMACY

3510 Bergenline Ave
Union City NJ 07087
(201)500-9366

$12.50

Get Your Coupon 8 more results found for GERIMED LTC NETWORK INC

COSTCO PHARMACY #1062

517 E 117 Th St
New York NY 10035
(212)896-5882

$12.50

Get Your Coupon 1 more results found for COSTCO PHARMACIES

Pregnancy

Pregnancy Risk Summary There are no adequate and well-controlled studies of ketamine in pregnant women. In animal reproduction studies in rats developmental delays (hypoplasia of skeletal tissues) were noted at 0.3 times the human intramuscular dose of 10 mg/kg. In rabbits, developmental delays and increased fetal resorptions were noted at 0.6 times the human dose. Published studies in pregnant primates demonstrate that the administration of anesthetic and sedation drugs that block NMDA receptors and/or potentiate GABA activity during the period of peak brain development increases neuronal apoptosis in the developing brain of the offspring when used for longer than 3 hours. There are no data on pregnancy exposures in primates corresponding to periods prior to the third trimester in humans. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2–4% and 15–20%, respectively. Clinical Considerations Since the safe use in pregnancy, including obstetrics (either vaginal or abdominal delivery), has not been established, such use is not recommended (see ANIMAL PHARMACOLOGY AND TOXICOLOGY ). Data Animal Data Pregnant rats were treated intramuscularly with 20 mg/kg ketamine (0.3 times the human intramuscular dose of 10 mg/kg based on body surface area) on either Gestation Days 6 to 10 or Gestation Days 11 to 15. Ketamine treatment produced an increased incidence of hypoplastic skull, phalanges, and sternebrae in the pups. Pregnant rabbits were treated intramuscularly with 20 mg/kg ketamine (0.6 times the human intramuscular dose of 10 mg/kg based on body surface area) on either Gestation Days 6 to 10 or Gestation Days 11 to 15. An increase in resorptions and skeletal hypoplasia of the fetuses were noted. Additional pregnant rabbits were treated intramuscularly with a single dose 60 mg/kg (1.9 times the human intramuscular dose of 10 mg/kg based on body surface area) on Gestation Day 6 only. Skeletal hypoplasia was reported in the fetuses. In a study where pregnant rats were treated intramuscularly with 20 mg/kg ketamine (0.3 times the human intramuscular dose of 10 mg/kg based on body surface area) from Gestation Day 18 to 21. There was a slight increase in incidence of delayed parturition by one day in treated dams of this group. No adverse effects on the litters or pups were noted; however, learning and memory assessments were not completed. Three pregnant beagle dogs were treated intramuscularly with 25 mg/kg ketamine (1.3 times the human intramuscular dose of 10 mg/kg based on body surface area) twice weekly for the three weeks of the first, second, and third trimesters of pregnancy, respectively, without the development of adverse effects in the pups. In a published study in primates, administration of an anesthetic dose of ketamine for 24 hours on Gestation Day 122 increased neuronal apoptosis in the developing brain of the fetus. In other published studies, administration of either isoflurane or propofol for 5 hours on Gestation Day 120 resulted in increased neuronal and oligodendrocyte apoptosis in the developing brain of the offspring. With respect to brain development, this time period corresponds to the third trimester of gestation in the human. The clinical significance of these findings is not clear; however, studies in juvenile animals suggest neuroapoptosis correlates with long-term cognitive deficits. (See WARNINGS/Pediatric Neurotoxicity , Pediatric Use , and ANIMAL TOXICOLOGY AND PHARMACOLOGY ).

Drug Interactions

Drug Interactions Prolonged recovery time may occur if barbiturates and/or narcotics are used concurrently with ketamine. Ketamine is clinically compatible with the commonly used general and local anesthetic agents when an adequate respiratory exchange is maintained.

Indications And Usage

INDICATIONS AND USAGE Ketamine hydrochloride injection is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. Ketamine hydrochloride injection is best suited for short procedures but it can be used, with additional doses, for longer procedures. Ketamine hydrochloride injection is indicated for the induction of anesthesia prior to the administration of other general anesthetic agents. Ketamine hydrochloride injection is indicated to supplement low-potency agents, such as nitrous oxide. Specific areas of application are described in the CLINICAL PHARMACOLOGY Section.

Overdosage

OVERDOSAGE Respiratory depression may occur with overdosage or too rapid a rate of administration of ketamine, in which case supportive ventilation should be employed. Mechanical support of respiration is preferred to administration of analeptics.

Adverse Reactions

ADVERSE REACTIONS Cardiovascular: Blood pressure and pulse rate are frequently elevated following administration of ketamine alone. However, hypotension and bradycardia have been observed. Arrhythmia has also occurred. Respiration: Although respiration is frequently stimulated, severe depression of respiration or apnea may occur following rapid intravenous administration of high doses of ketamine. Laryngospasms and other forms of airway obstruction have occurred during ketamine anesthesia. Eye: Diplopia and nystagmus have been noted following ketamine administration. It also may cause a slight elevation in intraocular pressure measurement. Psychological: (See Special Note). Neurological: In some patients, enhanced skeletal muscle tone may be manifested by tonic and clonic movements sometimes resembling seizures (see DOSAGE AND ADMINISTRATION Section). Gastrointestinal: Anorexia, nausea and vomiting have been observed; however, this is not usually severe and allows the great majority of patients to take liquids by mouth shortly after regaining consciousness (see DOSAGE AND ADMINISTRATION Section). General: Anaphylaxis. Local pain and exanthema at the injection site have infrequently been reported. Transient erythema and/or morbilliform rash have also been reported. For medical advice about adverse reactions contact your medical professional. To report SUSPECTED ADVERSE REACTIONS, contact Hospira, Inc. at 1-800-441-4100 or electronically at ProductComplaintsPP@hospira.com, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Contraindications

CONTRAINDICATIONS Ketamine hydrochloride is contraindicated in those in whom a significant elevation of blood pressure would constitute a serious hazard and in those who have shown hypersensitivity to the drug.